Transcriptional consequences of genomic structural aberrations in breast cancer.

Using a long-span, paired-end deep sequencing strategy, we have comprehensively identified cancer genome rearrangements in eight breast cancer genomes. Herein, we show that 40%-54% of these structural genomic rearrangements result in different forms of fusion transcripts and that 44% are potentially translated. We find that single segmental tandem duplication spanning several genes is a major source of the fusion gene transcripts in both cell lines and primary tumors involving adjacent genes placed in the reverse-order position by the duplication event. Certain other structural mutations, however, tend to attenuate gene expression. From these candidate gene fusions, we have found a fusion transcript (RPS6KB1-VMP1) recurrently expressed in ∼30% of breast cancers associated with potential clinical consequences. This gene fusion is caused by tandem duplication on 17q23 and appears to be an indicator of local genomic instability altering the expression of oncogenic components such as MIR21 and RPS6KB1.

[1]  Y. Ruan,et al.  Genome wide full-length transcript analysis using 5' and 3' paired-end-tag next generation sequencing (RNA-PET). , 2012, Methods in molecular biology.

[2]  Chee Seng Chan,et al.  Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. , 2011, Genome research.

[3]  J. Li,et al.  PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. , 2010, Cancer cell.

[4]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[5]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[6]  E. Liu,et al.  An Oestrogen Receptor α-bound Human Chromatin Interactome , 2009, Nature.

[7]  Li Li,et al.  Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers , 2009, Molecular Cancer Research.

[8]  Christopher W. Wong,et al.  RCP is a human breast cancer-promoting gene with Ras-activating function. , 2009, The Journal of clinical investigation.

[9]  T. Rabbitts,et al.  Commonality but Diversity in Cancer Gene Fusions , 2009, Cell.

[10]  M. Gerstein,et al.  A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. , 2009, Blood.

[11]  Christopher A. Miller,et al.  A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. , 2009, Genome research.

[12]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[13]  J. Sklar,et al.  A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells , 2008, Science.

[14]  Lil Pabon,et al.  A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. , 2008, Cell stem cell.

[15]  Joshua M. Korn,et al.  Mapping and sequencing of structural variation from eight human genomes , 2008, Nature.

[16]  Ali Bashir,et al.  Evaluation of Paired-End Sequencing Strategies for Detection of Genome Rearrangements in Cancer , 2008, PLoS Comput. Biol..

[17]  R. Shah,et al.  Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.

[18]  S. Varambally,et al.  Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. , 2008, Cancer research.

[19]  Benjamin J. Raphael,et al.  A sequence-based survey of the complex structural organization of tumor genomes , 2008, Genome Biology.

[20]  Laura A. Sullivan,et al.  Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.

[21]  Jason I. Herschkowitz,et al.  ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. , 2007, Cancer cell.

[22]  Philip M. Kim,et al.  Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome , 2007, Science.

[23]  H. Aburatani,et al.  Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.

[24]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[25]  Atif Shahab,et al.  Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). , 2007, Genome research.

[26]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[27]  Joshy George,et al.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.

[28]  H. Hamm,et al.  DEP domains: More than just membrane anchors. , 2006, Developmental cell.

[29]  L. Du,et al.  Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes , 2006, Nucleic acids research.

[30]  Raffaele Fronza,et al.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. , 2006, Carcinogenesis.

[31]  Benjamin J. Raphael,et al.  Decoding the fine-scale structure of a breast cancer genome and transcriptome. , 2006, Genome research.

[32]  J. Tchinda,et al.  Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.

[33]  Y. Tominaga,et al.  Translational Deregulation in PDK-1−/− Embryonic Stem Cells , 2005, Molecular and Cellular Biology.

[34]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[35]  B. Habermann,et al.  Translational Control of Putative Protooncogene Nm23-M2 by Cytokines via Phosphoinositide 3-Kinase Signaling* , 2004, Journal of Biological Chemistry.

[36]  Byungkook Lee,et al.  Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Preiss,et al.  Translational profiling: the genome-wide measure of the nascent proteome. , 2004, Briefings in functional genomics & proteomics.

[38]  Fergus J. Couch,et al.  The 17q23 Amplicon and Breast Cancer , 2003, Breast Cancer Research and Treatment.

[39]  M. Potter,et al.  Lymphoma‐ and leukemia‐associated chromosomal translocations in healthy individuals , 2003, Genes, chromosomes & cancer.

[40]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[41]  O. Kallioniemi,et al.  Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer † , 2002, Genes, chromosomes & cancer.

[42]  P. Sorensen,et al.  Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. , 2002, Cancer cell.

[43]  R. Roberts,et al.  Human Genome and Diseases:¶WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases , 2001, Cellular and Molecular Life Sciences CMLS.

[44]  Y. Chen,et al.  Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.

[45]  Y. Zheng,et al.  The Dbl family of oncogenes. , 1996, Current opinion in cell biology.